Search

everythinglearnresearchcommunity

for

Search:↓

Baricitinib was effective in treating both early and late onset alopecia areata.

PROTAC technology shows promise for cancer treatment but needs more effective E3 ligase recruiters.

The combination therapy is effective and well-tolerated for treating esophageal cancer.

ETC-159 was safe up to 30 mg, but no tumor shrinkage was seen.

Clascoterone is safe for the heart, even at high doses.

HPH-15, a new compound, effectively reduces skin fibrosis in experiments without causing harm.

Cepharanthine shows promise as a potential lung cancer treatment by effectively killing cancer cells.

ASLAN004 was safe and well-tolerated, supporting further development for treating certain diseases.

PRMT5 inhibitors effectively fight adenoid cystic carcinoma in salivary glands.

Ritlecitinib effectively regrows scalp, eyebrow, and eyelash hair in Asians with alopecia areata and is safe.

Ritlecitinib is the first FDA-approved pill for treating significant hair loss in alopecia areata patients aged 12 and up.

Baricitinib helped improve hair, eyebrow, and eyelash growth in alopecia areata patients.

Tofacitinib significantly improved hair loss and lesions in a patient with overlapping autoimmune disorders.

Baricitinib helps treat severe hair loss in people over 65.

Baricitinib was effective in treating hair loss in adults with alopecia areata according to patient feedback.

Baricitinib shows promise for treating alopecia areata with mild side effects.

Lysocellin helps stop cell damage from etoposide and may prevent hair loss.

Tofacitinib effectively treated a woman's complex autoimmune and autoinflammatory disorders.

Certain herbal compounds, especially from bitter melon, can inhibit cancer growth and promote hair growth by blocking PAK1.

Baricitinib treatment helped reduce hair loss symptoms in mice by decreasing inflammation-related immune cells.

CT-707 is effective and safe for treating certain Chinese lung cancer patients.

Baricitinib is effective and safe for treating severe alopecia areata with ongoing use.

ALRN-6924 can protect hair follicles from chemotherapy damage by temporarily stopping cell division.

CDK inhibitors may help treat ARDS and psoriasis but need more testing for safety and effectiveness.

Baricitinib shows promise in improving frontal fibrosing alopecia symptoms.

Baricitinib helps patients with severe alopecia areata regrow hair.

Cladribine has known risks and potential new safety concerns, requiring careful monitoring.

A new genetic mutation in the CAST gene may link PLACK syndrome to alopecia areata.